Stocks are reflections of human interest, and as such they are not paragons of truth. A single strand of misinformation could have catastrophic implications for a stock, which is what happened to PDS Biotechnology Corporation (NASDAQ: PDSB). After an allegation concerning the validity of its trial results was circulated online, the stock sank 51%. That said, the...
AMEX:SPY is trading sharply higher to start the week post long weekend as a provisional agreement was reached among lawmakers to increase the national debt limit, averting a potential default. This news coincided with an early rally in the market, led primarily by shares of Nvidia, a leading chipmaker and AI firm. SPY had been edging higher each time a new...
PDSB overbought on ER. Generally not a fan of biotech and pharma stocks. This spike is overdone the ANALysts claim this is a $14 stock (where were they when it was $2?) blah blah blah. We should correct under $7 in coming weeks
PDSB ahead of earnings could be crazy bullish cross on rsi and macd, i know im not the only one seeing this, how are more people not posting ideas in relation? am i missing something
Bizarre action yesterday, but this is one where I think shorts could be trapped if it gets back over $11.5. Really interesting chart and hoping we can get some form of a breakout over that area for a potential squeeze, even though this daily chart isn’t the greatest looking thing.
Here are some small cap breakout plays that I am looking at this week. Remember these are risky and could easily turn red if something goes wrong. Be careful and good luck!
My Watchlist:
$PDSB
$ESEA
$ORRF
$KRUS
$ACY
~$130mm market cap biotech firm, with multiple products in the pipeline based on their patented Versamune nanoparticle platform.
Recently spiked on announcement of award of $60mm from Brazilian Ministry of Science & Technology to fund phase 1/2 clinical trials for a potential Covid vaccine based on their Verasmune platform.
Since the news, avg vol (10day) is...
